Clinical and Radiographic Outcomes After AMIC Treatment for Talus Osteochondral Lesion Trattamento Artroscopico Delle Lesioni Osteocondrali Dell'Astragalo Con Tecnica AMIC

ConditionsTalar Osteochondral Defect of Ankle Pain Arthroscopy

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-65

SponsorI.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

About this trial

Aim of the study is to evaluate clinical and radiographic outcomes in patients undergone all-arthroscopic autologous matrix induced chondrogenesis for symptomatic osteochondral talar lesions

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age over 18 years

males and females

patients underwent arthroscopic cartilage reconstruction surgery with AMIC technique for osteochondral lesions of the talus

Disqualifiers

age <18 years at the time of surgery

patients with previous surgery on the affected ankle

Trial design

Design model

Single group

Treatments tested in this trial

AT-AMIC (arthroscopic talus autologous matrix induced chondrogenesis)
Other intervention
to fill arthroscopically osteochondral talar lesion

Treatment groups

103 Participants

are divided into 1 treatment group

Group A: Chondro-gide - GeistlichOther 1 intervention

Trial outcomes

Primary outcomes

Radiologic reduction of the lesion

A reduction of at least 30% of the lesion is to be expected

Time frame

5 years

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

Lead sponsor

Source ClinicalTrials.gov

Apply now